Beyond NT-proBNP and troponin: How machine learning redefines light-chain cardiac amyloidosis risk assessment | BMC Medical Informatics and Decision Making
Kumar SK, Callander NS, Adekola K, Anderson LD Jr., Baljevic M, Campagnaro E, Castillo JJ, Costello C, D’Angelo…